The FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid vaccine going forward ...

Future COVID-19 vaccines and boosters should be bivalent – meaning they’ll target older strains of the virus as well as the newer omicron BA.4 and BA.5 variants – following a unanimous recommendation ...

The U.S. Food and Drug Administration's vaccine advisory panel on Thursday voted unanimously to recommend that the agency ...

A panel of independent experts that advises the Food and Drug Administration on vaccines has backed a proposal to use the ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

Protecting against Covid infection with the current mRNA technology is unrealistic, a vaccine expert said in a paper ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

Novavax said Friday it expects its Covid-19 vaccine to remain “an important part” of the country’s immunization plan, as regulators work to develop a long-term strategy to protect the public from the ...

Moderna and the Food and Drug Association (FDA) have been accused of concealing data during the approval process for the pharma giant's bivalent Covid booster. Vaccine advisors who signed off on ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...